Humacyte HUMA
NASDAQ HUMA
$0.59 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST

Humacyte (HUMA) Notes Payables (2020 - 2021)

Updated

Humacyte (HUMA) reported Notes Payables of $7,172 for Q1 2021, down 92.5% from the prior quarter.

Analysis

Humacyte (HUMA) Notes Payables (2020 - 2021) Analysis & Trends

At the end of FY2020, Humacyte posted Notes Payables of $95,136.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Humacyte 163.90 Mn -213.24 Mn -401,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 7,172.00
Dec 31, 2020 95,136.00
Sep 30, 2020 89,076.00
API Access

Humacyte Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=HUMA&period=max&api_key=YOUR_API_KEY